The COVID 19 pandemic led to significant disruptions in health services, including immunisation programs, which contributed to a major post-pandemic diphtheria outbreak in Kano State, Nigeria. This region accounted for 85% of the nation's documented diphtheria cases. This study examined the epidemiology, clinical characteristics, and mortality outcomes of cases diagnosed between February 2022 and April 2024. Data were collected through the Surveillance Outbreak Response Management and Analysis System (SORMAS), and case definitions followed WHO guidelines. Case fatality rate (CFR) was calculated, and a logistic regression model was used to assess mortality-related risk factors, reporting adjusted odds ratios (AOR). A total of 18,320 cases were analysed, with the outbreak showing a bimodal distribution. The primary peak occurred in August 2023, followed by a smaller secondary peak in early 2024. The case fatality rate (CFR) was 4.5%. Patients who were not vaccinated had more than double the likelihood of death compared to fully vaccinated individuals (AOR 2.45; 95% CI: 2.05, 2.94, p < 0.0001; logistic regression). Similarly, patients without vaccination documentation also had greater odds, with more than 87% increase likelihood of mortality compared to fully vaccinated individuals (AOR 1.87, 95% CI: 1.27, 2.68, p < 0.0001; logistic regression). Our study reinforces previous reports of the weakening preventive health delivery systems in resource constrained settings, particularly after the disruptions caused by the COVID 19 pandemic leading to the resurgence of vaccine preventable diseases, such as diphtheria. These highlight the need for improved vaccination coverage and surveillance systems. This research did not receive any external funding.
Antibodies (Abs) are important immune mediators and powerful diagnostic markers in a wide range of infectious diseases. Understanding the humoral immunity or the development of effective antibodies against SARS-CoV-2 is a prerequisite for limiting disease burden in the community and aids in the development of new diagnostic, therapeutic, and vaccination options. Accordingly, the role of antiviral antibodies in the resistance to and diagnosis of SARS-CoV-2 infection was explored. Antibody testing showed the potential in adding important diagnostic value to the routine diagnosis and clinical management of COVID-19. They could also play a critical role in COVID-19 surveillance, allowing for a better understanding of the full scope of the disease. The development of several vaccines and the success of passive immunotherapy suggest that anti-SARS-CoV-2 antibodies have the potential to be used in the treatment and prevention of SARS-CoV-2 infection. In this review, we highlight the role of antibodies in the diagnosis of SARS-CoV-2 infection and provide an update on their protective roles in controlling SARS-CoV-2 infection as well as vaccine development.
9 May 2025 in International Journal of Maternal and Child Health and Aids
Healthcare-associated infections (HAIs) pose critical threats to maternal and child health in low-resource settings, with Kano State, Nigeria, reporting 6.3% of national HAI burdens and 85% of diphtheria cases. Despite global infection prevention and control (IPC) advancements, implementation gaps persist. This study engaged 50 multidisciplinary stakeholders including Kano State CDC, WHO, UNICEF, healthcare leaders, and community representatives through a three-day participatory workshop to co-develop a context-specific IPC framework. Key outcomes included standardized state IPC guidelines, facility-level monitoring committees, enhanced healthcare worker training, post-exposure prophylaxis (PEP) protocols, and dedicated isolation centers. The initiative reduced HAIs by 42% ( p < 0.01 ) in pilot facilities, with notable improvements in pediatric and maternal wards. Barriers such as inconsistent PPE access (reported by 68% of staff) were addressed through localized solutions, including community health worker engagement. Aligned with WHO’s Strategic Goal Five and SDG targets for quality care and antimicrobial resistance (AMR) reduction, this model demonstrates how stakeholder-driven IPC strategies can mitigate outbreaks in high-burden settings. Findings advocate for scalable, participatory approaches to strengthen health systems, directly impacting maternal-child survival and AMR containment in Nigeria and similar regions.
30 November 2019 in The Journal of Infection in Developing Countries
Introduction: An earlier constructed recombinant BCG expressing the MSP-1C of Plasmodium falciparum, induced inflammatory responses leading to significant production of nitric oxide (NO) alongside higher expression of the enzyme inducible nitric oxide synthase (iNOS) and significant production of the regulatory cytokine, IL-10, indicating significant immunomodulatory effects of the construct. The mechanism of these responses had not been established but is thought to involve toll-like receptor 4 (TLR-4). Methodology: The present study was carried out to determine the role of TLR-4 on eliciting the immunomodulatory effects of recombinant BCG expressing MSP-1C of Plasmodium falciparum leading to the production of NO and IL-10, as well as the expression of iNOS. Six groups of mice (n = 6 per group) were immunised thrice, three weeks apart with intraperitoneal phosphate buffered saline T80 (PBS-T80), BCG or rBCG in the presence or absence of a TLR-4 inhibitor; TAK-242, given one hour prior to each immunisation. Peritoneal macrophages were harvested from the mice and cultured for the determination of NO, iNOS and IL-10 via Griess assay, ELISA and Western blot respectively. Results: The results showed significant inhibition of the production of NO and IL-10 and the expression of iNOS in all groups of mice in the presence of TAK-242. Conclusions: These results presented evidence of the role of TLR-4/rBCG attachment mechanism in modulating the production of NO and IL-10 and the expression of iNOS in response to our rBCG-based malaria vaccine candidate expressing MSP-1C of P. falciparum.
30 June 2022 in UMYU Journal of Microbiology Research (UJMR)
Malaria is a serious public health concern worldwide, particularly in hyper endemic areas of tropical and subtropical regions, including Nigeria. This study investigated haematological profile of children under five (5) years infected with malaria attending Murtala Muhammad Specialist Hospital, Kano-Nigeria. Venous blood was aseptically collected from the ante-cubital vein. Thick and thin blood films were prepared and viewed under a light microscope to identify and quantify the malaria parasites. The study involved 160 children randomly selected: comprising of 80 malaria positive and 80 negative children. Full blood count was estimated using SYSMEX auto-hematology analyzer (Lincolnshire, Illinois U.S.A.). The results showed that red blood cells were statistically lower in malaria infected (3.64±1.09×10⁶/µL) compared to the controls (4.16±0.86×10⁶/µL). Haemoglobin concentration (HGB) of malaria infected children was also lower (8.78±3.14g/dl) than that of the control group (10.56±2.33g/dl). Similarly, hematocrit percentage of the infected children was significantly lower (25.58±6.28%) compared to the controls of (27.03±7.35%). The platelet count (PLT) of the malaria children were also lower in the case group (172.27±120.65×10³/µL) compared to the controls with (240.73±143.23×10³/µL), (P>0.05). While the total White Blood Cell counts (WBC) and its differentials did not show any statistically significant difference between the malaria infected and the controls (p>0.05). This study clearly demonstrated that malaria significantly affects the haematological profile of children under five years of age leading to anemia and thrombocytopenia, with no effects on the white blood cells and differentials.
1 January 2026 in African Journal of Laboratory Medicine
Background: Antimicrobial resistance (AMR) is a major global public health threat. ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) pose a major threat owing to resistance to last-line antibiotics. Genomic surveillance is crucial to understanding global and regional antimicrobial resistance genes (ARGs) in AMR transmission. Aim: This systematic review synthesised global genomic evidence to identify global and region-specific ARGs distribution among ESKAPE pathogens. Methods: Following PRISMA guidelines, studies published January 2019 to December 2024 were identified from PubMed, Google Scholar, and Web of Science. Eligible studies reported genomic characteristics and resistance patterns of one or more ESKAPE pathogens from any source. Results: Seventy-seven studies were included, with most originating from Asia, followed by Europe and Africa. Clinical isolates predominated K. pneumoniae was the most frequently investigated pathogen, followed by S. aureus, P. aeruginosa, and A. baumannii. The most reported resistance genes were blaCTX-M, blaNDM, and blaSHV. Distinct regional patterns of antimicrobial resistance gene (ARG) distribution were observed, with tetracycline and quinolone resistance genes prevailing in Africa and South America, and blaOXA variants dominating in Asia and Europe. Region-specific ARG patterns were identified through descriptive synthesis and comparative analysis of study-reported frequencies. Conclusion: This review provides a synthesised global map of ARG distribution in ESKAPE pathogens, highlighting surveillance gaps in underrepresented regions and non-clinical settings. Addressing these gaps will support targeted genomic surveillance and stewardship programmes. What this study adds: This study contributes to the body of knowledge by mapping global and regional antimicrobial resistance gene patterns in ESKAPE pathogens, identifying key surveillance gaps and informing targeted AMR monitoring and stewardship strategies.